Evidence map›Paper›PMID 33441767›Full record

ArticleScientific reports2021

A role for orphan nuclear receptor liver receptor homolog-1 (LRH-1, NR5A2) in primordial follicle activation.

Marie-Charlotte Meinsohn, Camilla H K Hughes, Anthony Estienne, Hatice D Saatcioglu, David Pépin, Raj Duggavathi, Bruce D Murphy

Open access · goldAbstract read
In one paragraph

Article in Scientific reports, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 22 papers.

0numbers the graph read from it
0cells of the map it votes in
22citing papers in PubMed
4.9field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

22 citing papers in PubMed, 38 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Differential Expression Characteristics of Two IsoformsAnimals : an open access journal from MDPI · 2025
    Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Loss of ERβ Disrupts Gene Regulation in Primordial and Primary Follicles.International journal of molecular sciences · 2024
    Article
  14. Article
  15. Steroidogenic factor 1 (SF-1;Proceedings of the National Academy of Sciences of the United States of America · 2023
    Article
  16. Article
  17. A screen of repurposed drugs identifies AMHR2/MISR2 agonists as potential contraceptives.Proceedings of the National Academy of Sciences of the United States of America · 2022
    Article
  18. Article
  19. Single-cell sequencing reveals suppressive transcriptional programs regulated by MIS/AMH in neonatal ovaries.Proceedings of the National Academy of Sciences of the United States of America · 2021
    Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 3 institutions in 2 countries.

Marie-Charlotte MeinsohnCentre de recherche en reproduction et fertilité, Université de Montréal, 3200 rue Sicotte, St-Hyacinthe, QC, J2S 7C6, Canada.
Camilla H K HughesCentre de recherche en reproduction et fertilité, Université de Montréal, 3200 rue Sicotte, St-Hyacinthe, QC, J2S 7C6, Canada.
Anthony EstienneCentre de recherche en reproduction et fertilité, Université de Montréal, 3200 rue Sicotte, St-Hyacinthe, QC, J2S 7C6, Canada.
Hatice D SaatciogluPediatric Surgical Research Laboratories, Simches Research Center, Massachusetts General Hospital, 185 Cambridge St., Boston, MA, 02114, USA.
David PépinPediatric Surgical Research Laboratories, Simches Research Center, Massachusetts General Hospital, 185 Cambridge St., Boston, MA, 02114, USA.
Raj DuggavathiDepartment of Animal Science, McGill University, 21111 Lakeshore Rd., MS1085, Ste-Anne de Bellevue, QC, H9X 3V9, Canada.
Bruce D MurphyCentre de recherche en reproduction et fertilité, Université de Montréal, 3200 rue Sicotte, St-Hyacinthe, QC, J2S 7C6, Canada. bruce.d.murphy@umontreal.ca.
Université de Montréal · CAMassachusetts General Hospital · USMcGill University · CA

Funding

Methods of fertility protection by Mullerian inhibiting substance in the female reproductive tract during chemotherapyR01HD102014 · NICHD · MASSACHUSETTS GENERAL HOSPITAL · PI PEPIN, DAVID · 2020 to 2024
$1.8M
NICHD NIH HHS R01 HD102014
6 · The paper itself

Abstract

Liver receptor homolog-1 (NR5A2) is expressed specifically in granulosa cells of developing ovarian follicles where it regulates the late stages of follicle development and ovulation. To establish its effects earlier in the trajectory of follicular development, NR5A2 was depleted from granulosa cells of murine primordial and primary follicles. Follicle populations were enumerated in neonates at postnatal day 4 (PND4) coinciding with the end of the formation of the primordial follicle pool. The frequency of primordial follicles in PND4 conditional knockout (cKO) ovaries was greater and primary follicles were substantially fewer relative to control (CON) counterparts. Ten-day in vitro culture of PND4 ovaries recapitulated in vivo findings and indicated that CON mice developed primary follicles in the ovarian medulla to a greater extent than did cKO animals. Two subsets of primordial follicles were observed in wildtype ovaries: one that expressed NR5A2 and the second in which the transcript was absent. Neither expressed the mitotic marker. KI-67, indicating their developmental quiescence. RNA sequencing on PND4 demonstrated that loss of NR5A2 induced changes in 432 transcripts, including quiescence markers, inhibitors of follicle activation, and regulators of cellular migration and epithelial-to-mesenchymal transition. These experiments suggest that NR5A2 expression poises primordial follicles for entry into the developing pool.

Indexed as

AnimalsFemaleGene DeletionGene ExpressionMiceMice, Inbred C57BLOvarian FollicleReceptors, Cytoplasmic and NuclearTranscriptomeNr5a2 protein, mouseReceptors, Cytoplasmic and Nuclear

Identifiers

PMID33441767
PMCPMC7807074
OpenAlexW3119482829

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.